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Abstract
Background. Bloodstream infection (BSI) is a life-threatening condition that
requires rapid antimicrobial treatment. Methods. We determined the prevalence
of bacterial isolates associated with BSI at Bukavu General Hospital (BGH),
South Kivu Province, Democratic Republic of the Congo, and their patterns
of susceptibility to antimicrobial drugs, from February 2013 to January 2014.
Results. We cultured 112 clinically relevant isolates from 320 blood cultures.
Of these isolates, 104 (92.9%) were Gram-negative bacteria (GNB), with 103
bacilli (92.0%) and one coccus (0.9%). Among GNB, Escherichia coli (51.9%),
Klebsiella spp. (20.2%), Enterobacter spp. (6.7%), Shigella spp. (5.8%) and
Salmonella spp. (4.8%) were the most frequent agents causing BSIs. Other GNB
isolates included Proteus spp., Citrobacter spp. and Pseudomonas aeruginosa
(both 2.9%), and Acinetobacter spp. and Neisseria spp. (both 0.9%). High rates
of resistance to co-trimoxazole (100%), erythromycin (100%) and ampicillin (6...
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Bloodstream infection (BSI) refers to the presence 
of microbial pathogens in the blood. These are 
present as a result of infection, not specimen 
contamination.[1-3] BSI is a major cause of community 
and healthcare-associated infections and is associated 
with high mortality.[3-7]
Infectious diseases are the leading cause of death in the Democratic 
Republic of the Congo (DRC).[8] In fact, the DRC has a crude 
mortality rate well above the average for sub-Saharan countries[9] 
and the highest under-5 mortality rate in Africa,[10] with malaria, 
pneumonia and diarrhoea the leading causes of death.[11,12] In South 
Kivu Province, most healthcare facilities lack the capacity to identify 
causative agents of infectious diseases reliably, including invasive 
bacterial infections such as BSIs. BSI and malaria are practically 
indistinguishable on clinical examination,[13] and available World 
Health Organization (WHO) guidelines for managing childhood 
illnesses fail to identify up to half of the cases of BSI.[14] In view of 
the fact that fever – a symptom common to malaria and BSI – is 
the most frequent reason for presentation to hospital in most 
developing countries,[5,15] the development of laboratory capacity 
for identification of pathogens is critical in order to improve the 
outcome of febrile diseases and enable rapid differential diagnosis 
between malaria and BSI.[16,17] We report the results of our first year’s 
experience using blood cultures in the laboratory of Bukavu General 
Hospital (BGH), South Kivu Province, in order to identify pathogens 
involved in BSIs. This report follows on from a previous study that 
documented a high rate of antimicrobial drug-resistant isolates in 
patients with urinary tract infections at the same healthcare facility.[18]
Methods
Study design
This cross-sectional study was conducted in inpatients in various 
wards of BGH who were suspected of having BSI. This hospital has 
385 beds, handles 6 400 admissions and 4 900 outpatients per year, 
and is one of the main healthcare facilities in Bukavu, a city of more 
than 500 000 inhabitants in South Kivu Province in eastern DRC.
Laboratory methods
BAC/ALERT FA FAN Aerobic and BAC/ALERT FA FAN Anaerobic 
blood culture bottles and BAC/ALERT PF Pediatric FAN (Biomérieux, 
Belgium) were dispatched to various wards of the hospital. The decision 
to perform blood culture was based on the following criteria: fever 
(temperature >38.0°C), a negative thick blood smear for detection of 
Plasmodium spp., and a white blood cell count of >10 × 109/L with 
>70% neutrophils. Nurses were instructed to sample blood during 
a febrile episode. For sampling, the patient’s skin was cleaned with 
70% ethanol and allowed to dry prior to venous puncture. Blood was 
collected using strict aseptic technique, and approximately 10 mL 
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ceftazidime, ceftriaxone, cefuroxime and cefepime were observed among GNB. Furthermore, there were high rates of multidrug resistance 
and of extended-spectrum β-lactamase (ESBL) production phenotype among Enterobacteriaceae. Gram-positive bacteria included 
three Staphylococcus aureus isolates (2.7%), four oxacillin-resistant coagulase-negative staphylococci (CoNS) isolates (3.6%) and one 
Streptococcus pneumoniae (0.9%). No oxacillin-resistant S. aureus was isolated. Among clinically relevant staphylococci, susceptibility to 
co-trimoxazole and ampicillin was low (0 - 25%). In addition, 58 contaminant CoNS were isolated from blood cultures, and the calculated 
ratio of contaminants to pathogens in blood cultures was 1:2.
Conclusions. Multidrug-resistant and ESBL-producing GNB are the leading cause of BSI at BGH.
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for adult patients was immediately inoculated 
into the BAC/ALERT FA FAN Aerobic and 
BAC/ALERT FA FAN Anaerobic blood culture 
bottles. In the case of children, 2 - 5 mL 
of blood was inoculated in a BAC/ALERT 
PF Pediatric FAN. The inoculated vials were 
incubated straight away at 37°C for up to 7 
days. The vials were checked visually every 
day to detect any colour change at the bottom 
of the bottle, from a blue-green to a yellow 
colour. For vials displaying a positive signal, 
cultures were Gram-stained and subcultures 
performed on 5% sheep blood agar plates 
for staphylococci. For Streptococcus, a disc of 
optochin was added to the streaked blood agar 
plate and incubation was carried out at 37°C 
in a 5% CO2 atmosphere. Subculture of Gram-
negative bacilli was performed on MacConkey 
agar, whereas Gram-negative cocci were 
subcultured on chocolate agar. Standard 
biochemical methods were subsequently used 
to identify bacteria at the species level.[19]
Antimicrobial susceptibility tests 
were performed using the disc diffusion 
method on Mueller-Hinton agar II (Bio-
Rad, Nazareth Eke, Belgium), and the 
results were interpreted according to the 
guidelines of the European Committee on 
Antimicrobial Susceptibility Testing (EUCAST, 
2015).[20] Antibiotic discs were purchased 
from Bio-Rad (Nazareth Eke). For isolates 
of staphylococci, testing of antimicrobial 
drug susceptibility to ampicillin, amikacin, 
clindamycin, erythromycin, gentamicin, 
oxacillin and vancomycin was performed. 
In order to assess the antimicrobial drug 
susceptibility pattern of Gram-negative 
isolates, ampicillin, gentamicin, amoxicillin-
clavulanic acid, ceftriaxone, cefuroxime, 
ceftazidime, cefepime, imipenem, amikacin, 
ciprofloxacin, erythromycin and clindamycin 
were tested. Isolates showing resistance to 
at least one cephalosporin were tested for 
extended-spectrum β-lactamase (ESBL) 
production by the double-disc synergy test 
on Mueller-Hinton agar using ceftazidime 
and ceftriaxone placed at a distance of 20 
mm from a disc containing amoxicillin plus 
clavulanic acid. A clear-cut enhancement of 
the inhibition in front of either ceftazidime 
and ceftriaxone discs towards the clavulanic 
acid-containing disc (also called ‘champagne 
cork’ or ‘keyhole’) was interpreted as 
positive for ESBL production.[21] E-test 
strips (BioMérieux, France) were used for 
confirmation of ESBL production. Minimum 
inhibitory concentrations of cefotaxime and 
ceftazidime, with and without clavulanic 
acid, were determined after 16 - 18 hours’ 
incubation on Mueller-Hinton plates 
inoculated with suspension of isolates at a 
fixed density (0.5 - 0.6 McFarland standard). 
Escherichia coli ATCC 35218 and Klebsiella 
pneumoniae ATCC 700603 strains were 
used as ESBL-negative and positive controls, 
respectively. Multidrug resistance (MDR) 
was defined as non-susceptibility to at least 
one agent in three or more antimicrobial 
categories.[16] All MDR isolates were 
cryopreserved at –80°C for further studies, 
with the exception of methicillin-resistant 
coagulase-negative staphylococci (CoNS), all 
CoNS being considered contaminants.
Statistical analysis
Statistical analyses were performed using 
the SPSS statistical package release 12.0 
for Windows (SPSS, USA). Comparisons 
of proportions of bacteria isolated and 
antimicrobial susceptibility results were 
analysed using the χ2 test. The level of 
significance was p<0.05.
Ethics
Ethical approval was granted by the Ethical 
Committee of the Université catholique de 
Bukavu, DRC, and the DRC Ministry of 
Health. The study complies with WHO and 
international guidelines (European Society of 
Clinical Microbiology and Infectious Diseases 
Study Group for Antimicrobial Resistance 
Surveillance and Clinical Laboratory Standards 
Institute) on antibiotic surveillance, for which 
no recommendation for an informed consent 
has been issued. The diagnostic procedure 
(blood cultures) is part of the standard 
diagnostic work-up of patients suspected of 
having bacteraemia. Clinical information 
as presented, and information about use of 
antibiotics, was the standard information 
on the laboratory request form. Data were 
reviewed and analysed anonymously.
Results
A total of 320 blood samples from 320 
different patients were cultured. The 
mean age of the patients was 21.6 years 
(range 0 - 75), and 162 were males and 158 
females. Bacterial pathogens were detected 
in 170 cultures, 29.4% of which were from 
children (<17 years). The distribution and 
percentages of the various bacterial isolates 
are shown in Table 1.
Isolates of Gram-negative bacteria (GNB) 
(104, 61.2%) were significantly more prevalent 
than Gram-positive isolates (66, 38.8%) 
(p<0.05). Among the Gram-positive isolates, 
the predominant isolate was CoNS (n=62); of 
these, 58 were susceptible to oxacillin. Four 
CoNS isolates displayed low susceptibility to 
oxacillin and were accordingly considered 
methicillin-resistant CoNS. Staphylococcus 
aureus was represented by three isolates, none 
resistant to oxacillin. Only one S. pneumoniae 
was isolated, from a blood sample of a 
3-year-old girl; this isolate was resistant to 
erythromycin and amikacin, while retaining 
susceptibility to gentamicin. The Gram-negative 
isolates were overwhelmingly represented 
by Enterobacteriaceae (100/104 isolates). 
Enterobacteriaceae included E. coli (48.6%), 
Klebsiella spp. (18.9%) and Enterobacter spp. 
(6.3%). Rare Enterobacteriaceae included 
Shigella spp., Salmonella spp, Citrobacter spp. and 
Table 1. Distribution of isolates in blood cultures at BGH, February 2013 - January 2014 
Bacterial isolate Isolates, n
% of total isolates 
(N=170)
% of BSI pathogens 
(N=112)
Escherichia coli 54 31.8 48.2
Klebsiella spp. 21 12.4 18.3
Enterobacter spp. 7 4.1 6.3
Shigella spp. 6 3.5 5.4
Salmonella spp. 5 2.9 4.5
Citrobacter spp. 3 1.8 2.7
Pseudomonas aeruginosa 3 1.8 2.7
Proteus spp. 3 1.8 2.7
Acinetobacter spp. 1 0.6 0.9
Neisseria spp. 1 0.6 0.9
Staphylococcus aureus 3 1.8 2.7
Methicillin-resistant CoNS 4 2.4 3.6
Streptococcus pneumoniae 1 0.6 0.9
Methicillin-susceptible CoNS 
(contaminants)
58 34.1 -
Total 170 100 100
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Proteus spp. The four non-Enterobacteriaceae 
Gram-negative isolates included three 
Pseudomonas aeruginosa, one Acinetobacter spp. 
and one Neisseria spp.
Tables 2 and 3 show the antimicrobial 
susceptibility patterns of Gram-negative and 
Gram-positive bacterial isolates. With the 
exception of the two Proteus spp., Gram-
negative isolates were often susceptible to 
amikacin, gentamicin and ciprofloxacin. The 
MDR phenotype was present in 36 (34.6%) 
Gram-negative isolates, with >50% also 
displaying an ESBL-production phenotype. 
Indeed, 82% MDR E. coli isolates were also 
ESBL producers, whereas 100% of Klebsiella 
spp. isolates displayed the ESBL-production 
phenotype. Of note, all Gram-negative bacilli 
displayed low susceptibility to co-trimoxazole, 
ampicillin and erythromycin. Worryingly, two 
MDR and ESBL-producing Klebsiella spp. 
isolates also displayed resistance to imipenem, 
one of the few carbapenems available in the 
province.
Nitrofurantoin, an oral drug displaying 
satisfactory activity against uropathogens 
in South Kivu,[18] was not included in the 
antimicrobial panel because only parenteral 
antimicrobials were administered for the 
treatment of BSIs.
Discussion
BSI is associated with high mortality and high 
healthcare costs, especially when the bacteria 
have low susceptibility to antimicrobial 
drugs.[22] Accordingly, the implementation of 
laboratory capacity for specific diagnosis of 
causative bacterial agents and determination 
of their antimicrobial susceptibility profile 
is pivotal in curbing mortality related to 
BSI. Although blood cultures have been 
performed at our hospital for many years, 
they were characterised by a very low 
yield of positive isolates, with unreliable 
identification resulting in largely empirical 
treatment of presumptive BSI. Changes in 
the blood culture process in the past year 
have resulted in a spectacular rise in positive 
blood cultures in patients with suspected BSI. 
Despite these encouraging improvements, 
blood culture at our hospital is still plagued 
by a high rate of contaminant CoNS, when 
compared with benchmarks in the field.[23,24] 
Action must therefore be taken to improve 
skin decontamination prior to blood 
sampling; the low susceptibility of CoNS to 
oxacillin needs further confirmation, as it 
has been shown that disc testing is not an 
accurate method for the determination of 
methicillin susceptibility of CoNS.[25]
In our study, 32.5% of blood cultures 
yielded significant positive growth. This rate 
Table 2. Antimicrobial resistance (%) in 104 Gram-negative blood isolates collected at BGH, February 2013 - January 2014
Antimicrobial 
drug
Escherichia 
coli (n=54)
Klebsiella 
spp. 
(n= 21)
Enterobacter 
spp. (n=7)
Citrobacter 
spp. (n=3)
Salmonella 
spp. (n=5)
Shigella 
spp. 
(n=6)
Proteus 
spp. 
(n=3)
Acinetobacter 
spp. (n= 1)
Pseudomonas 
aeruginosa 
(n=3)
Neisseria 
spp. 
(n=1)
Amikacin 5.6 4.8 0 0 0 0 66.7 0 0 0
Ampicillin 98.1 95.2 100.0 100.0 100.0 83.3 66.7 100 100 NT
Amoxicillin/
clavulanate
7.4 19.0 14.2 33.3 0 50.0 0 100 100 NT
Cefepime 13.0 91 57.1 33.3 0 83.3 66.7 NT NT NT
Ceftazidine 46.3 52.4 14.2 66.7 20 83.3 66.7 100 100 NT
Ceftriaxone 24.1 19.0 28.5 33.3 80 83.3 0 100 NT NT
Cefuroxine 81.5 85.7 85.6 66.7 80 100 100 100 66.7 NT
Ciprofloxacin 31.5 33.3 57.1 0 20 33.3 66.7 0 66.7 100
Erythromycin 100 100 100 100 100 100 100 100 100 NT
Gentamicin 7.4 28.6 14.2 0 100 100 66.7 0 0 NT
Imipenem 0 4.8 0 0 0 0 0 0 0 NT
Co-trimoxazole 100 100 100 100 100 100 100 100 100 100
MDR 
phenotype
20.4 47.6 57.1 66.7 0 66.7 0 100 100 0
ESBL-
producing 
phenotype
16.7 47.6 28.5 33.3 0 0 0 NT NT NT
NT = not tested.
Table 3. Antimicrobial resistance (%) in 8 Gram-positive blood isolates collected at 
BGH, February 2013 to January 2014
Antimicrobial drug tested
Staphylococcus 
aureus (3 isolates)
CoNS 
(4 isolates)
Streptococcus pneumoniae  
(1 isolate)
Amikacin 0 0 100.0
Ampicillin 100 75.0 NT
Sulphamethoxazole + 
trimethoprim
100 100 NT
Clindamycin 0 0 NT
Gentamicin 0.00 50.0 0
Erythromycin 33.3 0 0
Oxacillin 0 10.0 NT
Vancomycin 0 0 NT
NT = not tested.
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is high when compared with rates in other African countries.[22,26-28] 
We found a high prevalence of MDR GNB as major causative agents 
of BSI.
Among GNB, Enterobacteriaceae, particularly E. coli, were the 
most frequently isolated pathogens. Our results diverge from those 
previously reported in this province more than a decade ago that 
documented Salmonella spp. as the leading cause of bacteraemia in 
a rural paediatric hospital.[5] Oddly, Gram-positive bacteria did not 
play an important role in BSI when compared with other studies in 
developing countries;[15,27,29,30] in fact, only three S. aureus and one 
S. pneumoniae were isolated. Given this steadily growing danger of 
MDR and ESBL-producing isolates in South Kivu, as underlined by 
our findings, a strict antibiotic policy should be implemented urgently 
in the province with an emphasis on local susceptibility findings. 
Another important issue in the province is the lack of regulation 
regarding prescription of antibiotics, which are widely used, even for 
minor illnesses such as rhinitis. Whereas no study has assessed this 
phenomenon, it is worth noting that a recent study documented a high 
level of irrational prescription of antibiotics by healthcare professionals 
in the Orientale Province of DRC,[31] and that this practice is often 
associated with a steady increase of antimicrobial drug resistance in 
low-income countries. The identification of two carbapenem-resistant 
Klebsiella spp. isolates in the province is consistent with a recent 
observation of a carbapenem-resistant Enterobacter spp. in a urinary 
tract infection in the same province.[18] The emergence and possible 
spread of carbapenem-resistant Enterobacteriaceae isolates in the 
province would represent an additional step in the wrong direction that 
might be enhanced by misuse of carpabenems, as observed a few years 
ago in some Asian countries.[32]
Study limitations
Our study has several limitations. We analysed only 320 blood 
cultures, a low number that might result in selection bias. Rates 
obtained during this study should therefore be interpreted with 
caution. Whereas no patient reported having HIV infection, no 
objective data were available regarding HIV status of BSI patients.
Conclusion
Although performed on a limited set of blood cultures, our 
study underscores the high prevalence of MDR-resistant bacteria 
responsible for BSI at BGH. The high rate of MDR ESBL-producing 
GNB is consistent with a previous study performed on isolates 
from urinary tract infections at the same hospital. Accordingly, 
these findings should compel provincial healthcare stakeholders 
to take immediate action aimed at tackling this dangerous trend, 
before the situation slips beyond any possible repair. These actions 
should include the establishment of guidelines for prescription of 
antimicrobial drugs and the setting up of antimicrobial drug control 
in the province.
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